دورية أكاديمية

Belantamab Mafodotin in Combination with Vrd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-Vrd Trial

التفاصيل البيبلوغرافية
العنوان: Belantamab Mafodotin in Combination with Vrd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-Vrd Trial
المؤلفون: Gonzalez-Calle, Veronica *, Rodriguez Otero, Paula *, Rey-Bua, Beatriz *, De La Rubia, Javier *, De Arriba, Felipe *, Cabañas, Valentin *, Garcia, Esther González *, Ocio, Enrique M., Encinas, Cristina *, Suarez Cabrera, Alexia *, Bargay, Joan *, Martinez Lopez, Joaquin *, Gonzalez, Marta Sonia *, Hernandez-Rivas, Jose Angel *, Rosiñol, Laura *, Hernández, Miguel-Teodoro *, Paiva, Bruno *, Cedena Romero, Maria Teresa *, Puig, Noemi, Lahuerta, Juan-José *, Bladé, Joan *, San-Miguel, Jesús, Mateos, Maria-Victoria
المصدر: In Blood 15 November 2022 140 Supplement 1:7286-7288
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood-2022-162584